Mlys.o Share Price Today
(NASDAQ: MLYS)

Name: Mlys.o Share Price Today (NASDAQ: MLYS) - Mlys.o Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Mlys.o share price is $10.01 & ₹870.56 as on 6 Mar 2025, 2.30 'hrs' IST

$10.01

▲

0.09

(0.91%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Mlys.o share price in Dollar and Rupees. Guide to invest in Mlys.o stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mlys.o, along with analyst recommendations, forecasts, and comprehensive financials.

Mlys.o share price movements

Today's Low: $9.82
Today's High: $10.33
$10.01
1.95%
Downside
Day's Volatility :4.99%
Upside
3.1%
52 Weeks Low: $8.24
52 Weeks High: $15.25
$10.01
17.67%
Downside
52 Weeks Volatility :45.96%
Upside
34.36%

Mlys.o (MLYS) Returns

Period	Mlys.o	Index (Russel 2000)
3 Months	-18.82%	0.0%
6 Months	-16.92%	0.0%
1 Year	-29.14%	0.0%
3 Years	-46.2%	-11.6%

Mlys.o (MLYS) Key Statistics

in dollars & INR

Previous Close	$9.92
Open	$10.0
Today's High	$10.33
Today's Low	$9.815
Market Capitalization	$445.5M
Today's Volume	$130.5K
52 Week High	$15.25
52 Week Low	$8.241
Revenue TTM	$0.0
EBITDA	$-192.4M
Earnings Per Share (EPS)	$-3.66
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-82.24%

How to invest in Mlys.o Stock (MLYS) from India?

It is very easy for Indian residents to invest directly in Mlys.o from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mlys.o stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mlys.o or MLYS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mlys.o or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mlys.o shares which would translate to 0.087 fractional shares of Mlys.o as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mlys.o, in just a few clicks!

Returns in Mlys.o (MLYS) for Indian investors in Rupees

The Mlys.o stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Mlys.o investment value today

Current value as on today

₹76,463

Returns

₹23,537

(-23.54%)

Returns from Mlys.o Stock

₹28,500 (-28.5%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Mlys.o (MLYS)

100%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Mlys.o Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Mlys.o

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Mlys.o(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Mlys.o Stock (MLYS)

What analysts predicted

Upside of 219.68%

Target:

$32.00

Current:

$10.01

Insights on Mlys.o Stock (Ticker Symbol: MLYS)

Price Movement
In the last 7 days, MLYS stock has moved up by 2.5%
MLYS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 94.4%

Mlys.o Technicals Summary

Sell

Neutral

Buy

Mlys.o is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Mlys.o (MLYS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mlys.o	-2.84%	-16.92%	-29.14%	-46.2%	-46.2%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mlys.o	NA	NA	NA	-4.03	-0.82	-0.53	NA	3.84
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mlys.o	Buy	$445.5M	-46.2%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Mlys.o

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. The company's clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. It has initiated a Phase 2 trial for lorundrostat in hypertensive patients with stage 2 to 3b chronic kidney disease and a pivotal clinical program of lorundrostat for the treatment of uncontrolled or resistant hypertension. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Organization	Mlys.o
Employees	51
CEO	Mr. Jon Congleton
Industry	Healthcare

Management People of Mlys.o

Name	Title
Mr. Jon Congleton	CEO & Director
Mr. Adam Scott Levy	CFO & Secretary
Dr. David M. Rodman M.D.	Chief Medical Officer
Ms. Cindy Berejikian	Executive Vice President of Operations
Ms. Sarah Foster	Vice President of Human Resources
Dr. Robert McKean Ph.D.	Senior Vice President of CMC
Ms. Danielle Bradbury	Senior Vice President of Quality Assurance
Mr. Jeffrey N. Fellows	Senior Vice President of Regulatory Affairs
Ms. Jessica Ibbitson	Senior Vice President of Clinical Operations
Mr. Jose Breton CPA	Senior VP of Finance & Controller

Important FAQs about investing in MLYS Stock from India :

What is Mlys.o share price today?

Mlys.o share price today stands at $10.01, Open: $10.00 ; Previous Close: $9.92 ; High: $10.33 ; Low: $9.82 ; 52 Week High: $15.25 ; 52 Week Low: $8.24.

The stock opens at $10.00, after a previous close of $9.92. The stock reached a daily high of $10.33 and a low of $9.82, with a 52-week high of $15.25 and a 52-week low of $8.24.

Can Indians buy Mlys.o shares?

Yes, Indians can invest in the Mlys.o (MLYS) from India.

With INDmoney, you can buy Mlys.o at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Mlys.o at zero transaction cost.

How can I buy Mlys.o shares from India?

It is very easy to buy Mlys.o from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mlys.o (MLYS) be purchased?

Yes, you can buy fractional shares of Mlys.o with INDmoney app.

What are the documents required to start investing in Mlys.o stocks?

To start investing in Mlys.o, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.